Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Accident Prevention
19%
Acquired Immune Deficiency Syndrome
14%
Adherence
43%
Alzheimer's Disease
18%
Ambulatory Care
9%
Analgesia
8%
Antidepressant
15%
Antiretroviral Therapy
10%
Artificial Intelligence
13%
Body Mass
13%
Breast Cancer
32%
Cancer Screening
12%
Chronic Condition
17%
Chronic Disease
11%
Chronic Pain
17%
Clinical Pharmacy
9%
Clinical Skill
8%
Cohort Analysis
12%
Colorectal Carcinoma
11%
Comorbidity
14%
Confidence Interval
28%
Counseling
13%
COVID-19
12%
Cross-Sectional Study
31%
Diabetes Mellitus
20%
Diseases
21%
Drug Dependence
8%
Drug Therapy
18%
Drug Use
11%
Economic and Social Development
28%
Education
47%
Efficacy
10%
Elderly Patient
16%
Emergency Ward
13%
Glycemic Control
14%
Health Administration
18%
Health Care
34%
Health Care Cost
57%
Health Care Management
16%
Health Care Personnel
27%
Health Care Utilization
26%
Health Center
9%
Health Condition
8%
Health Outcomes
8%
Health Status
16%
Healthcare System
8%
Hemoglobin A1c
10%
Hospital Readmission
10%
Human Immunodeficiency Virus
39%
Hypertension
18%
Inflammatory Arthritis
8%
Influenza
12%
Insulin
8%
Length of Stay
11%
Logistic Regression Analysis
27%
Lung Cancer
15%
Malignant Neoplasm
18%
Mammography
13%
Maturity Onset Diabetes of the Young
29%
Medicaid
34%
Medicare
92%
Medication Compliance
19%
Mental Diseases
25%
Mental Health
21%
Meta Analysis
8%
Motivational Interviewing
9%
Multiple Chronic Conditions
14%
Nonsteroid Antiinflammatory Agent
8%
Obesity
8%
Obstructive Lung Disease
14%
Odds Ratio
36%
Opioid
25%
Osteoarthritis
17%
Outpatient
35%
Patient Care
14%
Patient Compliance
8%
Patient with Diabetes
10%
Patient with Type 2 Diabetes
8%
Pediatrics
8%
Pharmacy Student
42%
Pilot Study
8%
Pneumonia
10%
Polypharmacy
12%
Practice Experience
17%
Practice Guideline
23%
Prescription Drug
9%
Prevalence
24%
Preventive Health Service
11%
Preventive Medicine
10%
Primary Health Care
19%
Primary Medical Care
19%
Prostate Cancer
13%
Public Health
9%
Quality of Life
19%
Rheumatoid Arthritis
8%
Self Care
17%
Statin (Protein)
8%
Systematic Review
11%
Treatment Outcome
8%
Youth
9%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
73%
Acquired Immune Deficiency Syndrome
10%
Adverse Drug Reaction
9%
Adverse Event
31%
Alzheimer's Disease
21%
Antibiotics
6%
Anticoagulant Agent
13%
Antidepressant
28%
Antipsychotic
21%
Apixaban
7%
Asthma
6%
Atrial Fibrillation
13%
Atypical Antipsychotics
12%
Autism
7%
Base
7%
Bioavailability
7%
Bipolar Disorder
6%
Breast Cancer
10%
Buspirone
9%
Cholinesterase Inhibitor
10%
Chronic Obstructive Lung Disease
25%
Clinical Pharmacokinetics
8%
Clinical Pharmacy
7%
Clinical Study
8%
Clinical Trial
13%
Clozapine
37%
Clozapine N Oxide
9%
Cohort Study
20%
Colorectal Carcinoma
8%
Community Pharmacy
7%
Comorbidity
12%
Contraceptive Agent
10%
Cross Sectional Study
9%
CYP3A4
9%
Decanoic Acid
9%
Desmethylclozapine
8%
Diabetes Mellitus
8%
Diseases
43%
Drug Development
6%
Drug Interaction
23%
Drug-Drug Interaction
21%
Elimination
7%
End Stage Renal Disease
11%
Extrapyramidal Symptoms
6%
Fluvoxamine
8%
Global Disease Burden
7%
Grapefruit
7%
Haloperidol Decanoate
10%
Hansen's disease
7%
High Performance Liquid Chromatography
6%
HIV
55%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Hypertension
15%
Infection
10%
Inflammatory Arthritis
9%
Isoenzyme
6%
Major Depression
8%
Malignant Neoplasm
18%
Maturity Onset Diabetes of the Young
10%
Midazolam
6%
Non-Steroidal Anti-Inflammatory Drug
7%
Normal Human
11%
Observational Study
8%
Olanzapine
14%
Parkinson's Disease
11%
Pharmaceutical Care
9%
Pharmacodynamics
34%
Pharmacoeconomics
8%
Pharmacogenetics
10%
Pharmacokinetic Parameter
6%
Pharmacokinetics
100%
Pharmacotherapy
29%
Pharmacy Practice
21%
Placebo
11%
Polypharmacy
11%
Prescription Drug
33%
Prevalence
32%
Prospective Study
6%
Randomized Controlled Trial
6%
Reduced Haloperidol
54%
Remission
6%
Retrospective Study
6%
Rheumatoid Arthritis
9%
Risperidone
7%
Ritonavir
12%
Schizophrenia
18%
Selective Serotonin Reuptake Inhibitor
15%
Side Effect
19%
Statin (Protein)
21%
Tablet
10%
Tenofovir
6%
Therapeutic Drug Monitoring
18%
Tolerability
20%
Tuberculosis
7%
Typical Antipsychotic
10%
Vaccination
11%
Vancomycin
6%
Venous Thromboembolism
10%
Vitamin K Group
7%
Warfarin
15%
Keyphrases
95% Confidence Interval
20%
Acetylcholinesterase Inhibitors (AChEI)
8%
Adjusted Odds Ratio
17%
Adverse Effects
8%
African American
8%
AIDS/HIV
18%
Alzheime's Disease
15%
Alzheimer's Disease
15%
Antidepressants
20%
Arthritis
8%
Asthma
8%
Behavioral Risk Factor Surveillance System (BRFSS)
8%
Body Mass Index
15%
Breast Cancer
10%
Breast Cancer Patients
8%
Chi-square Test
8%
Chronic Disease
27%
Chronic Obstructive Pulmonary Disease
15%
Chronic Physical Illness
9%
Clozapine
21%
Clozapine-N-oxide
7%
Comorbidity
28%
COVID-19
17%
Dementia
7%
Depression Treatment
27%
Diabetes
37%
Diabetes Management
12%
Diabetes Mellitus
9%
Disability
7%
Drug Interactions
9%
Drug Use
8%
Economic Burden
8%
Elderly Patients
11%
Electronic Health Records
8%
Haloperidol
43%
Healthcare Costs
12%
Healthcare Expenditure
35%
Healthcare Utilization
11%
Heart Disease
8%
HIV-infected Patients
14%
Hospitalization
7%
Hypertension
15%
Immunization
8%
Influenza
7%
Logistic Regression
9%
Medicaid
16%
Medicaid Beneficiaries
15%
Medical Expenditure Panel Survey
8%
Medicare
8%
Medicare Beneficiaries
57%
Medicare Current Beneficiary Survey
7%
Medication Adherence
8%
Meta-analysis
29%
Multinomial Logistic Regression
9%
National Health Interview Survey
9%
New Jersey
11%
Newly Diagnosed
9%
NHANES
7%
Non-Hispanic White
9%
Obesity
8%
Odds Ratio
9%
Older Adults
26%
Older Adults with Diabetes
8%
Opioid Use
8%
Opioids
9%
Osteoarthritis
9%
Out-of-pocket
8%
Out-of-pocket Expenditure
11%
P2Y12 Inhibitors
7%
Parkinson's Disease
11%
Patients with Diabetes
8%
Pharmacist
28%
Pharmacokinetics
18%
Pharmacotherapy
7%
Pharmacy
12%
Pharmacy Education
7%
Pharmacy Students
13%
Plasma Concentration
18%
Plasma Parameters
10%
Prescription Drugs
9%
Prostate Cancer
10%
Psychotherapy
11%
Retrospective Cohort Study
13%
Rheumatoid Arthritis
10%
Risk Factors
17%
Schizophrenia
9%
Schizophrenic
34%
Selective Serotonin Reuptake Inhibitors
9%
Significant Predictors
10%
Statins
13%
Student Pharmacists
8%
Texas
8%
Treatment Options
9%
Treatment Patterns
8%
Type 2 Diabetes Mellitus (T2DM)
24%
United States
72%
Veterans Health Administration
14%
West Virginia
8%
Women Veterans
10%
Working Adults
12%